OpenVSafe by OpenVAERS
Search V-safe

FBM-30244-28415

2 vaccinations 4 coded responses 9 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
774 / TX
Registered
2021-04-05
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-04-05
    Registered in v-safe
  2. 2021-04-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  7. 2021-04-26
    Dose 2 — Pfizer-BioNTech
  8. 2021-05-03
    Health check-in — day 7, dose 2
    Feeling: Good · Joint pains
    Adult check-in
  9. 2021-06-04
    Survey response — day 35, dose 2
    MedDRA: Abdominal discomfort, Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Fatigue, cough, congestion, sore throat, gastric upset
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-06-09
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Muscle aches and fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-07-27
    Survey response — 3 months, dose 2
    MedDRA: Hypersensitivity, Sinus disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Increased sinus and allergy sensitivity
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  12. 2022-04-28
    Survey response — 12 months, dose 2
    MedDRA: Brain fog, Fatigue — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Constant fatigue and brain fog.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-04-28
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  14. 2022-05-02

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Pfizer-BioNTech
22021-04-26Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 8 — day 35, dose 2

2021-06-04

Symptoms: Fatigue, cough, congestion, sore throat, gastric upset

Release 9 — day 42, dose 2

2021-06-09

Symptoms: Muscle aches and fatigue

Release 9 — 3 months, dose 2

2021-07-27

Symptoms: Increased sinus and allergy sensitivity

Release 11 — 12 months, dose 2

2022-04-28

Symptoms: Constant fatigue and brain fog.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort ✓ ✓ ✓
SDBrain fog · · ✓
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHypersensitivity ✓ · ✓
SDMyalgia ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDSinus disorder ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release